NDCAX | PACAX | NDCAX / PACAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 31 years | - |
Gain YTD | -0.312 | -0.094 | 332% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 281M | 576M | 49% |
Annual Yield % from dividends | 3.37 | 2.18 | 154% |
Returns for 1 year | 2.70 | 8.16 | 33% |
Returns for 3 years | -2.12 | -1.04 | 204% |
Returns for 5 years | 7.10 | 7.60 | 93% |
Returns for 10 years | 18.74 | 18.19 | 103% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 65.55 | 0.33 | +0.51% |
Janus Henderson Global Life Sciences S | |||
FTZCX | 51.08 | -0.28 | -0.55% |
FullerThaler Behvrll Uncnstd Eq C | |||
DNLDX | 59.79 | -0.48 | -0.80% |
BNY Mellon Active MidCap A | |||
ICSCX | 29.39 | -0.26 | -0.88% |
William Blair Small Cap Value I | |||
FSYJX | 8.59 | -0.09 | -1.04% |
Fidelity Sustainable Emerging Markets Eq |